We are pleased to announce that Dr. Cristina Teixido, an esteemed member of the editorial board of Exploration of Targeted Anti-tumor Therapy（ETAT), recently attended the XXXII Congreso SEAP - IAP 2025, held from May 21 to 23 in Spain. This esteemed congress gathered leading oncology experts from around the world to discuss the advances in next-generation tumor sequencing technologies and personalized cancer therapies. Thanks to the help of Dr. Cristina Teixido, ETAT received prominent exposure at this congress.

Dr. Cristina Teixido delivered a presentation during this congress and introduced the ETAT journal at the end of her presentation, underscoring ETAT’s significant global impact as evidenced by its indexing in prominent databases such as PubMed/PMC, Google Scholar, Scopus and DOAJ. She also introduced the journal’s scope, the composition of the editorial board, the special issues currently open for submissions, and our submission benefits, which captured the attention of some attendees.

This provided direct access to a highly relevant audience of active researchers and gave an effective showcase for the journal among the community of cancer research experts. The ETAT editorial team expresses our sincere appreciation to Dr. Cristina Teixido for her exceptional efforts in promoting the journal at this high-profile event.

Looking ahead, ETAT remains dedicated to providing researchers with a premier platform for academic exchange and continues fostering cancer research in future scholarly activities.